Biobot Surgical Pte
Latest round
- Series C
Last raised
- Apr 2026
Total raised
- $34M
Investors
- 3
About Biobot Surgical Pte
Founded in 2007 by Sim Giok Lak and based in Singapore, Biobot Surgical Pte. Ltd. is a health tech company that focuses on robotic-assisted percutaneous surgical systems. The company uses technology to improve diagnostic and treatment accuracy for patients. As of 2022, Sim Kok Hwee is the CEO of the company. The company provides iSR’obot Mona Lisa, urofusion software, urobiopsy software, easel bed mount, and a biopsy kit. The firm's iSR’obot Mona Lisa is a robotic system that performs transperineal MRI-ultrasound fusion targeted prostate biopsy. Ltd. and ZIG Ventures.0 is a robotic-assisted percutaneous surgical system that allows clinicians to plan and position needles during image-guided diagnostic and interventional prostate procedures. Biobot Surgical's features include robotic needle guide positioning and depth control, prostate stability with ultrasound probe sheath, dual Cone technology, automated yet flexible biopsy planning, and elastic MRI-ultrasound fusion.
Who invested in Biobot Surgical Pte
3 investors across 3 rounds
See all investors in Biobot Surgical Pte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biobot Surgical Pte
Who invested in Biobot Surgical Pte?
Biobot Surgical Pte has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biobot Surgical Pte raised?
Biobot Surgical Pte has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Biobot Surgical Pte last raise money?
Biobot Surgical Pte's most recent round on record is a Series C, in Apr 2026.
What does Biobot Surgical Pte do?
Founded in 2007 by Sim Giok Lak and based in Singapore, Biobot Surgical Pte.
Where is Biobot Surgical Pte headquartered?
Biobot Surgical Pte is headquartered in Singapore, Singapore.
Which VCs invest in companies like Biobot Surgical Pte?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Biobot Surgical Pte's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Biobot Surgical Pte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.